MetLife Investment Management LLC Raises Position in Prometh

MetLife Investment Management LLC lifted its stake in shares of Prometheus Biosciences, Inc. (NASDAQ:RXDX – Get Rating) by 4.9% in the 4th quarter, HoldingsChannel reports. The firm owned 18,318 shares of the biopharmaceutical company’s stock after buying an additional 854 shares during the quarter. MetLife Investment Management LLC’s holdings in Prometheus Biosciences were worth $2,015,000 […]

Related Keywords

Canada , Alger , Algeria , Markc Mckenna , Piper Sandler , T Rowe Price Investment Management Inc , Metlife Investment Management , Fred Alger Management , Nasdaq , Royal Bank , Securities Exchange Commission , Prometheus Biosciences Inc , Goldman Sachs Group , Prometheus Biosciences , Get Rating , Life Investment Management , Street Corp , Alger Management , Price Investment Management , Rowe Price Investment Management , Sinai Intellectual Prop Cedars , Exchange Commission , Visit Holdingschannel , Prometheus Biosciences Daily , Nasdaq Rxdx , Rxdx , Medical , Sec Filings , 13f , Hedge Fund Holdings , Institutional Investor Holdings ,